Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will attend the ...

A new service is making it easier for primary care and community health professionals to monitor, treat and manage patients ...

Explore 5 grim ways fast food links to liver damage, from fatty buildup to inflammation, threatening health with every bite.

KUALA LUMPUR, April 16 (Bernama) -- The rising prevalence of obesity and diabetes in Malaysia is contributing to a surge in liver disease cases, with expert warning of serious long-term health ...

45% of cases had a co-existing diagnosis of liver cirrhosis (n=9), 35% chronic renal failure ... of iron deficiency anaemia on a background of cirrhotic liver disease or portal hypertension, ...

Recent advances have marked a turning point for the treatment noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), with more therapies on the horizon to hopefully better address ...

Background: It is currently recommended that all patients with liver cirrhosis undergo upper gastrointestinal endoscopy (UGIE) to identify those who have large esophageal varices (LEVx ...

The judge’s delay in approving the settlement has paved the way for a potential spending spree in football once the 10-day portal opens Wednesday. Without an approval, another uncapped portal ...

With travel warnings and revoked visas, the two superpowers locked in a bruising trade war may make students and tourists their bargaining chips. By Vivian Wang Reporting from Beijing China has ...

Weight-Loss Surgery Lowers Risk of Developing Complications of Liver Disease in Patients With Cirrhosis and Obesity Jan. 27, 2025 — A study shows that patients with obesity and fatty liver ...

In patients with liver disease, artificial intelligence-Cirrhosis-Electrocardiogram score predicted mortality and liver transplant outcomes.